HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Rosenson RS, Brewer HB, Chapman MJ, Fazio S, Hussain MM, Kontush A, Krauss RM, Otvos JD, Remaley AT, Schaefer EJ (2011) Clin Chem 57: 392-410 The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Corella D, Arnett DK, Tsai MY, Kabagambe EK, Peacock JM, Hixson JE, Straka RJ, Province M, Lai CQ, Parnell LD, Borecki I, Ordovas JM (2007) Clin Chem 53: 1144-52 Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function. May-Zhang LS, Yermalitsky V, Huang J, Pleasent T, Borja MS, Oda MN, Jerome WG, Yancey PG, Linton MF, Davies SS (2018) J Biol Chem 293: 9176-9187 Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women. Vajo Z, Terry JG, Brinton EA (2002) Atherosclerosis 160: 495-501 Speciated human high-density lipoprotein protein proximity profiles. Gauthamadasa K, Rosales C, Pownall HJ, Macha S, Jerome WG, Huang R, Silva RA (2010) Biochemistry 49: 10656-65
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.